Neuropsychiatric events in an adult patient with influenza a (H3N2) treated with oseltamivir (Tamiflu) : a case report
BACKGROUND: Total four influenza pandemics have happened since twentieth century, and currently influenza is in the seasonal epidemic around the world, with a sharp increase in its incidence each year. As an effective treatment of influenza infection, the use of oseltamivir is climbing globally. However, there have been reports of neuropsychiatric events associated with the drug, mainly in young patients and males. To our knowledge, this is the first reported case of oseltamivir-associated neuropsychiatric events occurring in an patient over 50-year-old.
CASE PRESENTATION: Here we present the case of a 57-year-old Chinese female with H3N2 influenza infection who developed abnormal psychiatric symptoms after administration of high doses of oseltamivir. The patient recovered completely within the cessation of oseltamivir.
CONCLUSIONS: We hope that our case report will lead clinicians to be mindful about oseltamivir's potential neuropsychiatric side effects, and to pay special attention to each patient's mental state, both in children and adults.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
---|---|
Enthalten in: |
BMC infectious diseases - 19(2019), 1 vom: 04. März, Seite 224 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chen, Ruochan [VerfasserIn] |
---|
Links: |
---|
Themen: |
20O93L6F9H |
---|
Anmerkungen: |
Date Completed 16.04.2019 Date Revised 25.02.2020 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/s12879-019-3827-4 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM294567933 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM294567933 | ||
003 | DE-627 | ||
005 | 20231225081750.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12879-019-3827-4 |2 doi | |
028 | 5 | 2 | |a pubmed24n0981.xml |
035 | |a (DE-627)NLM294567933 | ||
035 | |a (NLM)30832611 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chen, Ruochan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Neuropsychiatric events in an adult patient with influenza a (H3N2) treated with oseltamivir (Tamiflu) |b a case report |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.04.2019 | ||
500 | |a Date Revised 25.02.2020 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: Total four influenza pandemics have happened since twentieth century, and currently influenza is in the seasonal epidemic around the world, with a sharp increase in its incidence each year. As an effective treatment of influenza infection, the use of oseltamivir is climbing globally. However, there have been reports of neuropsychiatric events associated with the drug, mainly in young patients and males. To our knowledge, this is the first reported case of oseltamivir-associated neuropsychiatric events occurring in an patient over 50-year-old | ||
520 | |a CASE PRESENTATION: Here we present the case of a 57-year-old Chinese female with H3N2 influenza infection who developed abnormal psychiatric symptoms after administration of high doses of oseltamivir. The patient recovered completely within the cessation of oseltamivir | ||
520 | |a CONCLUSIONS: We hope that our case report will lead clinicians to be mindful about oseltamivir's potential neuropsychiatric side effects, and to pay special attention to each patient's mental state, both in children and adults | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Adult | |
650 | 4 | |a Neuropsychiatric events | |
650 | 4 | |a Oseltamivir | |
650 | 4 | |a Side effects | |
650 | 7 | |a Antiviral Agents |2 NLM | |
650 | 7 | |a RNA, Viral |2 NLM | |
650 | 7 | |a Oseltamivir |2 NLM | |
650 | 7 | |a 20O93L6F9H |2 NLM | |
700 | 1 | |a Fang, Zhixiong |e verfasserin |4 aut | |
700 | 1 | |a Huang, Yan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMC infectious diseases |d 2001 |g 19(2019), 1 vom: 04. März, Seite 224 |w (DE-627)NLM11120089X |x 1471-2334 |7 nnns |
773 | 1 | 8 | |g volume:19 |g year:2019 |g number:1 |g day:04 |g month:03 |g pages:224 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12879-019-3827-4 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 19 |j 2019 |e 1 |b 04 |c 03 |h 224 |